2015年,两种肺部疾病导致360万人死亡

2017-08-17 MedSci MedSci原创

根据星期四发表在《呼吸医学杂志》上的一项统计,两种最常见的慢性肺部疾病在2015夺去了全世界360万的生命。大约有320万人死于慢性阻塞性肺病(COPD),主要是由于吸烟和污染造成的,而40万人死于哮喘。慢性阻塞性肺病是一类引起呼吸困难的肺部疾病的总称,包括肺气肿和支气管炎。研究发现,哮喘的发病率是COPD的两倍,但COPD的致死率是前者的八倍。这两种疾病都可以得到很好的治疗,但许多患者往往没有得


根据星期四发表在《呼吸医学杂志》上的一项统计,两种最常见的慢性肺部疾病在2015夺去了全世界360万的生命。

大约有320万人死于慢性阻塞性肺病(COPD),主要是由于吸烟和污染造成的,而40万人死于哮喘。慢性阻塞性肺病是一类引起呼吸困难的肺部疾病的总称,包括肺气肿和支气管炎。

研究发现,哮喘的发病率是COPD的两倍,但COPD的致死率是前者的八倍。

这两种疾病都可以得到很好的治疗,但许多患者往往没有得到诊断、误诊或治疗不足。

根据世界卫生组织的数据,COPD是2015年全球第四大死亡原因,仅次于心脏病(900万)、中风(600万)和下呼吸道感染(略高于320万)。

华盛顿大学健康指标与评估研究所(Institute of Health Metrics and Evaluation)的教授西奥·沃斯(Theo Vos)领导的研究人员对来自188个国家,从1990年到2015年每年的病例和死亡人数的数据进行了分析与评估。

在此期间,慢性阻塞性肺病的患病率和死亡率都有所下降,但总体数字却在增加--由于人口增长,死亡率上升了近12%。

在全球范围内,哮喘患病率上升了近13%,达到3.58亿人,但死亡人数下降了四分之一。
沃斯在一份声明中说:"这些疾病比其他非传染性疾病如心血管疾病、癌症或糖尿病受到的关注少。"

研究显示,2015年COPD致残人口最多的国家是巴布亚新几内亚、印度、莱索托和尼泊尔。在哮喘方面,阿富汗、中非共和国、斐济、基里巴斯、莱索托、巴布亚新几内亚和斯威士兰都的患病率最高。

高收入的亚洲国家受COPD的影响最小,与中欧、北非、中东和西欧的国家一样。中欧和东欧,以及中国、日本和意大利,都是哮喘发病率最低的国家。

伦敦卫生与热带医学学院(London School of Hygiene & Tropical Medicine)教授尼尔·皮尔斯(Neil Pearce)说:"这项研究及时地提醒我们,我们必须重新集中精力抗击哮喘这种危险的疾病。"

他补充说:"我们对哮喘的原因仍然知之甚少,为什么全球范围内的发病率在增加。"

众所周知,吸烟会加重哮喘,无论是在室内还是室外。

作者指出,室内烹饪也是慢性肺部疾病的主要原因。


此文系梅斯医学(MedSci)原创整理编译,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=237015, encodeId=eaf323e015eb, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Fri Aug 25 15:42:15 CST 2017, time=2017-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1542299, encodeId=90ca15422999e, content=<a href='/topic/show?id=ab8d8235654' target=_blank style='color:#2F92EE;'>#肺部疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82356, encryptionId=ab8d8235654, topicName=肺部疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f7613405394, createdName=1249857fm36暂无昵称, createdTime=Sat Aug 19 07:26:00 CST 2017, time=2017-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=234862, encodeId=3815234862c1, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Fri Aug 18 23:30:13 CST 2017, time=2017-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=234497, encodeId=d68623449e04, content=不错的,学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Thu Aug 17 17:13:53 CST 2017, time=2017-08-17, status=1, ipAttribution=)]
    2017-08-25 三生有幸9135

    学习一下谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=237015, encodeId=eaf323e015eb, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Fri Aug 25 15:42:15 CST 2017, time=2017-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1542299, encodeId=90ca15422999e, content=<a href='/topic/show?id=ab8d8235654' target=_blank style='color:#2F92EE;'>#肺部疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82356, encryptionId=ab8d8235654, topicName=肺部疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f7613405394, createdName=1249857fm36暂无昵称, createdTime=Sat Aug 19 07:26:00 CST 2017, time=2017-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=234862, encodeId=3815234862c1, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Fri Aug 18 23:30:13 CST 2017, time=2017-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=234497, encodeId=d68623449e04, content=不错的,学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Thu Aug 17 17:13:53 CST 2017, time=2017-08-17, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=237015, encodeId=eaf323e015eb, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Fri Aug 25 15:42:15 CST 2017, time=2017-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1542299, encodeId=90ca15422999e, content=<a href='/topic/show?id=ab8d8235654' target=_blank style='color:#2F92EE;'>#肺部疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82356, encryptionId=ab8d8235654, topicName=肺部疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f7613405394, createdName=1249857fm36暂无昵称, createdTime=Sat Aug 19 07:26:00 CST 2017, time=2017-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=234862, encodeId=3815234862c1, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Fri Aug 18 23:30:13 CST 2017, time=2017-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=234497, encodeId=d68623449e04, content=不错的,学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Thu Aug 17 17:13:53 CST 2017, time=2017-08-17, status=1, ipAttribution=)]
    2017-08-18 三生有幸9135

    学习一下谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=237015, encodeId=eaf323e015eb, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Fri Aug 25 15:42:15 CST 2017, time=2017-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1542299, encodeId=90ca15422999e, content=<a href='/topic/show?id=ab8d8235654' target=_blank style='color:#2F92EE;'>#肺部疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82356, encryptionId=ab8d8235654, topicName=肺部疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f7613405394, createdName=1249857fm36暂无昵称, createdTime=Sat Aug 19 07:26:00 CST 2017, time=2017-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=234862, encodeId=3815234862c1, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Fri Aug 18 23:30:13 CST 2017, time=2017-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=234497, encodeId=d68623449e04, content=不错的,学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Thu Aug 17 17:13:53 CST 2017, time=2017-08-17, status=1, ipAttribution=)]
    2017-08-17 中医痴

    不错的,学习了,谢谢分享!

    0

相关资讯

FDA承诺加快对Boehringer肺部疾病药物审批

FDA最近表示将对勃林格殷格翰公司开发的用于治疗肺部疾病特发性肺纤维化(idiopathic pulmonary fibrosis (IPF))药物nintedanib进行优先审核。这一决定也将加快其上市的审批流程并在与InterMune公司相似药物竞争中迎头赶上。勃林格殷格翰公司进行了两项超过1000名患者参与的临床上拿起研究,分别发现nintedanib将患者肺功能年平均丧失率降低了4

BMJ研究新闻:过去十年肺部疾病所导致的死亡居高不下

来自英国肺脏基金会的一项综合报告显示,在过去的十年里,死于肺部疾病的患者人数几乎未发生变化,而且一些肺部疾病的发病率远高于既往所认为的发病率。英国 The Battle for Breath, the Impact of Lung Disease表明,每年有115000人死于肺病疾病 。在过去的十年里这一死亡人数并未下降,而心脏病所致的死亡人数从2008到2012减少了15%。在欧洲,英国的肺部疾

JCI & CHEST J:端粒突变更易患肺部疾病

近日,刊登在国际杂志Journal of Clinical Investigation及CHEST Journal上的两篇研究论文中,来自杨百翰大学的研究者表示,他们知道我们中的大部分人什么时候死亡?但研究者并不不清楚我们确切的死亡事件,当然他们得出这样的结论得益于对我们机体染色体生物钟的研究,染色体末端的端粒可以帮助预测机体的寿命,其越短就表示我们寿命越短。 较短的端粒可以帮助预测骨髓衰竭、肝